Terms: = Brain cancer AND H3F3B, H3_3A, 3021, ENSG00000132475, P84243, H3_3B, MGC87783, MGC87782, H3F3
16 results:
1. Diffuse hemispheric glioma with H3 p.K28M (K27M) mutation: Unusual non-midline presentation of diffuse midline glioma, H3 K27M-altered?
Donev K; Sundararajan V; Johnson D; Balan J; Chambers M; Paulson VA; Scherpelz KP; Abdullaev Z; Quezado M; Cimino PJ; Pratt D; Valerio E; Alves de Castro JV; Carraro DM; Torrezan GT; Wolff BM; Kulikowski LD; Costa FD; Aldape K; Ida CM
J Neuropathol Exp Neurol; 2024 Apr; 83(5):357-364. PubMed ID: 38447592
[TBL] [Abstract] [Full Text] [Related]
2. Liquid biopsy in H3K27M diffuse midline glioma.
Patel J; Aittaleb R; Doherty R; Gera A; Lau B; Messinger D; Wadden J; Franson A; Saratsis A; Koschmann C
Neuro Oncol; 2024 May; 26(Supplement_2):S101-S109. PubMed ID: 38096156
[TBL] [Abstract] [Full Text] [Related]
3. A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.
Auffret L; Ajlil Y; Tauziède-Espariat A; Kergrohen T; Puiseux C; Riffaud L; Blouin P; Bertozzi AI; Leblond P; Blomgren K; Froelich S; Picca A; Touat M; Sanson M; Beccaria K; Blauwblomme T; Dangouloff-Ros V; Boddaert N; Varlet P; Debily MA; Grill J; Castel D
Acta Neuropathol; 2023 Dec; 147(1):2. PubMed ID: 38066305
[TBL] [Abstract] [Full Text] [Related]
4. Knockout tales: the versatile roles of histone H3.3 in development and disease.
Klein RH; Knoepfler PS
Epigenetics Chromatin; 2023 Oct; 16(1):38. PubMed ID: 37814296
[TBL] [Abstract] [Full Text] [Related]
5. Correlation between Multiparametric MR Imaging and Molecular Genetics in Pontine Pediatric High-Grade Glioma.
Rameh V; Vajapeyam S; Ziaei A; Kao P; London WB; Baker SJ; Chiang J; Lucas J; Tinkle CL; Wright KD; Poussaint TY
AJNR Am J Neuroradiol; 2023 Jul; 44(7):833-840. PubMed ID: 37321859
[TBL] [Abstract] [Full Text] [Related]
6. Antisense oligonucleotide therapy for H3.3K27M diffuse midline glioma.
Zhang Q; Yang L; Liu YH; Wilkinson JE; Krainer AR
Sci Transl Med; 2023 Apr; 15(691):eadd8280. PubMed ID: 37043556
[TBL] [Abstract] [Full Text] [Related]
7. Update on quality assurance in neuropathology: Summary of the round robin trials on
Pohl S; Dimitrova L; Grassow-Narlik M; Jöhrens K; Acker T; Dohmen H; Herms J; Dorostkar M; Hartmann C; Hasselblatt M; Neumann M; Reifenberger G; Felsberg J; Schüller U; Zoubaa S; Lorenz J; Rothhammer-Hampl T; Mauch-Mücke K; Riemenschneider MJ
Clin Neuropathol; 2023; 42(3):112-121. PubMed ID: 36999511
[TBL] [Abstract] [Full Text] [Related]
8. brain Abnormalities in Patients with Germline Variants in
Alves CAPF; Sherbini O; D'Arco F; Steel D; Kurian MA; Radio FC; Ferrero GB; Carli D; Tartaglia M; Balci TB; Powell-Hamilton NN; Schrier Vergano SA; Reutter H; Hoefele J; Günthner R; Roeder ER; Littlejohn RO; Lessel D; Lüttgen S; Kentros C; Anyane-Yeboa K; Catarino CB; Mercimek-Andrews S; Denecke J; Lyons MJ; Klopstock T; Bhoj EJ; Bryant L; Vanderver A
AJNR Am J Neuroradiol; 2022 Jul; 43(7):1048-1053. PubMed ID: 35772801
[TBL] [Abstract] [Full Text] [Related]
9. Droplet digital PCR-based analyses for robust, rapid, and sensitive molecular diagnostics of gliomas.
Wolter M; Felsberg J; Malzkorn B; Kaulich K; Reifenberger G
Acta Neuropathol Commun; 2022 Mar; 10(1):42. PubMed ID: 35361262
[TBL] [Abstract] [Full Text] [Related]
10. The Evolving Molecular Landscape of High-Grade Gliomas.
Pinarbasi E; Pratt D
Cancer J; 2021 Sep-Oct 01; 27(5):337-343. PubMed ID: 34570447
[TBL] [Abstract] [Full Text] [Related]
11. A novel immune-related long non-coding RNA signature improves the prognosis prediction in the context of head and neck squamous cell carcinoma.
Chen L; Cai Z; Lyu K; Cai Z; Lei W
Bioengineered; 2021 Dec; 12(1):2311-2325. PubMed ID: 34167440
[TBL] [Abstract] [Full Text] [Related]
12. Electronic DNA Analysis of CSF Cell-free Tumor DNA to Quantify Multi-gene Molecular Response in Pediatric High-grade Glioma.
Bruzek AK; Ravi K; Muruganand A; Wadden J; Babila CM; Cantor E; Tunkle L; Wierzbicki K; Stallard S; Dickson RP; Wolfe I; Mody R; Schwartz J; Franson A; Robertson PL; Muraszko KM; Maher CO; Garton HJL; Qin T; Koschmann C
Clin Cancer Res; 2020 Dec; 26(23):6266-6276. PubMed ID: 33087334
[TBL] [Abstract] [Full Text] [Related]
13. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
14. Histone H3.3 G34 Mutations Alter Histone H3K36 and H3K27 Methylation In Cis.
Shi L; Shi J; Shi X; Li W; Wen H
J Mol Biol; 2018 May; 430(11):1562-1565. PubMed ID: 29689253
[TBL] [Abstract] [Full Text] [Related]
15. Distinct h3f3A and h3f3b driver mutations define chondroblastoma and giant cell tumor of bone.
Behjati S; Tarpey PS; Presneau N; Scheipl S; Pillay N; Van Loo P; Wedge DC; Cooke SL; Gundem G; Davies H; Nik-Zainal S; Martin S; McLaren S; Goodie V; Robinson B; Butler A; Teague JW; Halai D; Khatri B; Myklebost O; Baumhoer D; Jundt G; Hamoudi R; Tirabosco R; Amary MF; Futreal PA; Stratton MR; Campbell PJ; Flanagan AM
Nat Genet; 2013 Dec; 45(12):1479-82. PubMed ID: 24162739
[TBL] [Abstract] [Full Text] [Related]
16. Molecular neuro-oncology in clinical practice: a new horizon.
Weller M; Pfister SM; Wick W; Hegi ME; Reifenberger G; Stupp R
Lancet Oncol; 2013 Aug; 14(9):e370-9. PubMed ID: 23896276
[TBL] [Abstract] [Full Text] [Related]
